Status:
COMPLETED
Glycemic Response in Persons with Type 2 Diabetes
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This will be a randomized crossover design with nutrition supplement interventions.
Detailed Description
This will be a randomized crossover design with three oral nutrition supplement interventions. The subjects will be randomized to one of three interventions on three separate study days, one week apar...
Eligibility Criteria
Inclusion
- Age 20-75 years
- Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
- Hemoglobin A1C less than 9.0%
- Fasting blood glucose less than 180 mg
- Hematocrit levels within normal limits
- Having obtained his/her informed consent
Exclusion
- Abnormal thyroid function
- Creatinine \>2.0 mg/dl
- Potassium \<3.5 mEq/l
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
- Unable to give informed consent or follow instructions
- Current insulin therapy or insulin therapy within the past month
- Patient who are pregnant
- Allergies to milk, soy or any component of the test product
- Patient who in the investigators assessment cannot be expected to comply with treatment
- Currently participating or having participated in another clinical trial
- Patients with anemia
Key Trial Info
Start Date :
May 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04413357
Start Date
May 18 2020
End Date
August 11 2020
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orange County Research Center
Tustin, California, United States, 92780